DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Centanafadine
Centanafadine
Joel L. Young, M.D
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
ADHD Investor Event Presentation
Serotonin Transporter 5-HTT; SERT; SLC6A4
Dopamine Transporter DAT; SLC6A3
Pharmacotherapy of ADHD with Non- Stimulants
Optimizing Outcomes in ADHD Treatment: from Clinical Targets to Novel Delivery Systems Gregory W
ACNP 59Th Annual Meeting: Poster Session III
Adhd, Performance Enhancement, Or Cosmetic Neurology: Clinical and Ethical Issues
Current and Future Nonstimulants in the Treatment of Pediatric ADHD: Monoamine Reuptake Inhibitors, Receptor Modulators, And
Curriculum Vitae
Update in ADHD: Focus on Longer Term Medication Outcomes
Cns Spectrums
ADHD CASES Learning Objectives
Cotempla XR-ODT
Indice: Dalle Banche Dati Bibliografiche Pag. 2 91 109 121 132 145 Segnalazioni 161
Perspective Rxpipeline
Official Title: a Phase 3, Randomized, Double-Blind
Top View
Emerging Drugs for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD)
ADHD-Focus-On-Medications-Timothy-E.-Wilens.Pdf
Suffixes Used in the Selection of INN and Their Published INN May 2018
ADHD Overview
Neuronal Signaling
Safety and Efficacy of Centanafadine Sustained-Release
Adrenergic Receptor Beta Receptor
WO 2016/192680 Al 8 December 2016 (08.12.2016) P O P C T
2017 Medicines in Development for Mental Illnesses
72X48 Poster Template
2019 Medicines in Development for Mental Illnesses
Update on Treating ADHD
2016 Medicines in Development for Mental Health
FORMULATION MATTERS: OPTIMIZING TREATMENT for ADHD Learning Objectives
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri